MAPT and Alzheimer disease: Neurons from transgenic rats expressing a human truncated tau protein analogous to a variant form derived from sporadic AD showed higher sensitivity to agents inducing oxidative stress, such as glucose oxidase and buthionine sulfoximine (inhibitor of GSH synthesis) [15].